New Israeli start-up company is leading the way with a new medical device which is used at home to treat erectile dysfunction and could replace Viagra.
/PRNewswire/ The energy-based aesthetic devices market is estimated to grow by USD 1.75 billion from 2022 to 2027 at a CAGR of 8.5% according to Technavio..
/PRNewswire/ Endymed Ltd (TASE: ENDY), currently traded on the Tel Aviv Stock Exchange, is proud to announce that it has been granted FDA approval for the.
/PRNewswire/ Endymed Ltd (TASE: ENDY), currently traded on Tel Aviv Stock Exchange, is pleased to announce the appointment of Bill Scott as President of its.